stockportfolio.pro
CVS Health Corporation P/E Ratio 2007–2025
CVS Health Corporation (CVS) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +8.2%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 56.13 | +385.4% |
| FY 2024 | 11.56 | +4.7% |
| FY 2023 | 11.05 | -55.9% |
| FY 2022 | 25.06 | +70.6% |
| FY 2021 | 14.69 | +40.5% |
| FY 2020 | 10.46 | -11.7% |
| FY 2019 | 11.85 | — |
| FY 2018 | — | — |
| FY 2017 | 8.58 | -28.3% |
| FY 2016 | 11.96 | -22.4% |
| FY 2015 | 15.40 | -12.0% |
| FY 2014 | 17.50 | +29.0% |
| FY 2013 | 13.57 | +21.4% |
| FY 2012 | 11.17 | +2.4% |
| FY 2011 | 10.92 | +15.2% |
| FY 2010 | 9.47 | +11.7% |
| FY 2009 | 8.48 | -3.2% |
| FY 2008 | 8.76 | -35.9% |
| FY 2007 | 13.66 | — |
Source: CVS Health Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for CVS Health Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCVS Health Corporation — frequently asked questions
What is CVS Health Corporation's price-to-earnings ratio?
CVS Health Corporation (CVS) reported price-to-earnings ratio of 56.13 for fiscal year 2025, per its SEC filings.
How has CVS Health Corporation's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, CVS's price-to-earnings ratio grew at roughly 8.2% per year (compound annual rate), from 13.66 to 56.13.
Where does this data come from?
Figures are computed from CVS Health Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.